Chinese regulator approves personalised cancer vaccine trial
Drug Discovery World
MARCH 30, 2023
According to data and analytics company Globaldata, the approval of LK101 injection sets the stage for exciting developments in the field. Vaccines predicated on neoantigens therefore elicit truly tumour-specific T cell responses.
Let's personalize your content